... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2025 Heart failure Kidney disease Cardiorenal medicine Cardionephrology Year 2023 In 2024, there were a multitude of new developments in the field of cardiorenal medicine...

... disease, and patients with kidney disease are at increased risk of heart failure. The co-occurrence of both entities not only significantly increases morbidity and mortality but also complicates therapy. Summary: Cardiorenal syndrome often requires a broad, comprehensive, and multidisciplinary approach...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Heart failure Kidney disease Cardiorenal medicine Cardionephrology Year 2023 In 2023, there were several new developments in the field of cardionephrology...

...Peter P. Toth; Sephy Philip; Michael Hull; Craig Granowitz Background: Dyslipidemia in kidney disease (KD) involves increased levels of triglycerides (TG) and TG-rich lipoproteins, with only minor changes in low-density lipoprotein cholesterol. The increasing prevalence of diabetic KD...

...) and kidney disease. Their benefits and efficacy are widely accepted in current clinical practice, but like any other therapeutic agents, they have adverse effects. One of the emerging concerns with statin therapy is the development of new-onset diabetes mellitus (NODM), a dreaded risk factor for CVD...

...Karen M. Vuckovic; Houry Puzantian Background/Aims: The 6-minute walk test is a measure of functional capacity in patients with heart failure (HF) or chronic kidney disease (CKD). The association between estimated glomerular filtration rate (eGFR) and 6-minute walk distance (6MWD) has not been...

... mortality in patients with chronic kidney disease (CKD) who have undergone percutaneous coronary intervention (PCI). Methods: In this study we included 293 consecutive patients with CKD who underwent PCI between 1st January 2007 and 30th September 2012. The primary outcome that we studied was all-cause...